Drug
DRUG 601 clinical trials
Also written Drug 601.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses DRUG 601 is read from its arms, and is right about nine times in ten.
Testing it · 4
- 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)CompletedPhase 2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.NCT04667910Written as 601 1.25mg
- 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedPhase 2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.NCT04667897Written as 601 1.25mg
- The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)Status unknownPhase 1Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.NCT04468997Written as Drug 601
- The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)Status unknownPhase 1Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.NCT04151407Written as Drug 601